Ausgabe 1/2011
Inhalt (13 Artikel)
Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer
Hideyuki Ubukata, Hiroyuki Nagata, Takanobu Tabuchi, Satoru Konishi, Teruhiko Kasuga, Takafumi Tabuchi
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature
Hideaki Shimada, Shinichi Okazumi, Masamichi Koyama, Koji Murakami
Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas
Ichiro Oda, Seiichiro Abe, Chika Kusano, Haruhisa Suzuki, Satoru Nonaka, Shigetaka Yoshinaga, Hirokazu Taniguchi, Tadakazu Shimoda, Takuji Gotoda
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification
Satoru Iwasa, Yasuhide Yamada, Takeo Fukagawa, Takako Eguchi Nakajima, Ken Kato, Tetsuya Hamaguchi, Shinji Morita, Makoto Saka, Hitoshi Katai, Yasuhiro Shimada
Depth-predicting score for differentiated early gastric cancer
Seiichiro Abe, Ichiro Oda, Taichi Shimazu, Tetsu Kinjo, Kazuhiro Tada, Taku Sakamoto, Chika Kusano, Takuji Gotoda
Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer
Yasuto Uchikado, Hiroshi Okumura, Sumiya Ishigami, Tetsuro Setoyama, Masataka Matsumoto, Tetsuhiro Owaki, Yoshiaki Kita, Shoji Natsugoe
Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis
Francesco Montagnani, Gina Turrisi, Claudio Marinozzi, Camillo Aliberti, Giammaria Fiorentini
Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway
Satoru Nonaka, Ichiro Oda, Teruo Nakaya, Chika Kusano, Haruhisa Suzuki, Shigetaka Yoshinaga, Takeo Fukagawa, Hitoshi Katai, Takuji Gotoda
Adjuvant chemoradiation for resected gastric cancer: a 10-year experience
Amy T. Y. Chang, Wai Tong Ng, Ada L. Y. Law, Ki Man Ku, Michael C. H. Lee, Anne W. M. Lee
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
Hiroyuki Narahara, Hiroyasu Iishi, Hiroshi Imamura, Akira Tsuburaya, Keisho Chin, Haruhiko Imamoto, Taito Esaki, Hiroshi Furukawa, Chikuma Hamada, Yuh Sakata
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer
Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki
Trans-vaginal specimen extraction following totally laparoscopic subtotal gastrectomy in early gastric cancer
Sang-Ho Jeong, Young-Joon Lee, Won Jun Choi, Won Young Paik, Chi-Young Jeong, Soon-Tae Park, Sang-Kyung Choi, Soon-Chan Hong, Eun-Jung Jung, Young-tae Joo, Woo-Song Ha